CTLT - צמיחת מכירות משנה לשנה (TTM) catalent.com

לוגו גרפי של Catalent, Inc (CTLT)

Catalent, Inc. relies on costly cGMP capacities that create an insurmountable barrier to entry for competitors. This trailing twelve-month revenue chart visualizes the impact of these barriers, while -13.40 shows the current value of the metric. The company's impeccable reputation ensures deep trust from the largest pharma behemoths. However, geopolitical tensions and sanctions periodically hinder global research and disrupt raw material logistics.

Catalent - צמיחת מכירות משנה לשנה (TTM) CTLT (תקופה 11.02.2024 - 20.02.2024)

Catalent, Inc (CTLT) - פילוחי מדדים ודוחות פיננסיים

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
ניתוח כל מדדי החברה:Catalent, Inc. - CTLT
מוצרים מיוצרים של Catalent Pharma Solutions

Investors utilize this metric as an objective marker of commercial expansion, assessing revenue growth rates over the last twelve months relative to the preceding period. By analyzing the trailing twelve-month (TTM) sales growth, one can confirm the revenue stability of Catalent, Inc. (CTLT), which is driven by high switching costs and the company's deep integration into the critical R&D processes of major pharmaceutical behemoths.